vs
Cytek Biosciences, Inc.（CTKB）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是READING INTERNATIONAL INC的1.2倍（$62.1M vs $50.3M），READING INTERNATIONAL INC净利率更高（-5.1% vs -70.9%，领先65.8%），Cytek Biosciences, Inc.同比增速更快（8.1% vs -14.2%），READING INTERNATIONAL INC自由现金流更多（$4.1M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 5.6%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
CTKB vs RDI — 直观对比
营收规模更大
CTKB
是对方的1.2倍
$50.3M
营收增速更快
CTKB
高出22.3%
-14.2%
净利率更高
RDI
高出65.8%
-70.9%
自由现金流更多
RDI
多$5.9M
$-1.8M
两年增速更快
CTKB
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $50.3M |
| 净利润 | $-44.1M | $-2.6M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | -1.9% |
| 净利率 | -70.9% | -5.1% |
| 营收同比 | 8.1% | -14.2% |
| 净利润同比 | -557.1% | -14.5% |
| 每股收益（稀释后） | — | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBRDI
| Q4 25 | $62.1M | $50.3M | ||
| Q3 25 | $52.3M | $52.2M | ||
| Q2 25 | $45.6M | $60.4M | ||
| Q1 25 | $41.5M | $40.2M | ||
| Q4 24 | $57.5M | $58.6M | ||
| Q3 24 | $51.5M | $60.1M | ||
| Q2 24 | $46.6M | $46.8M | ||
| Q1 24 | $44.9M | $45.1M |
净利润CTKBRDI
| Q4 25 | $-44.1M | $-2.6M | ||
| Q3 25 | $-5.5M | $-4.2M | ||
| Q2 25 | $-5.6M | $-2.7M | ||
| Q1 25 | $-11.4M | $-4.8M | ||
| Q4 24 | $9.6M | $-2.2M | ||
| Q3 24 | $941.0K | $-7.0M | ||
| Q2 24 | $-10.4M | $-12.8M | ||
| Q1 24 | $-6.2M | $-13.2M |
毛利率CTKBRDI
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBRDI
| Q4 25 | -9.0% | -1.9% | ||
| Q3 25 | -17.6% | -0.6% | ||
| Q2 25 | -23.3% | 4.8% | ||
| Q1 25 | -36.1% | -17.2% | ||
| Q4 24 | 5.2% | 2.6% | ||
| Q3 24 | -8.2% | -0.6% | ||
| Q2 24 | -18.3% | -16.4% | ||
| Q1 24 | -23.9% | -16.7% |
净利率CTKBRDI
| Q4 25 | -70.9% | -5.1% | ||
| Q3 25 | -10.5% | -8.0% | ||
| Q2 25 | -12.2% | -4.4% | ||
| Q1 25 | -27.5% | -11.8% | ||
| Q4 24 | 16.8% | -3.8% | ||
| Q3 24 | 1.8% | -11.7% | ||
| Q2 24 | -22.4% | -27.4% | ||
| Q1 24 | -13.8% | -29.4% |
每股收益（稀释后）CTKBRDI
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $-0.18 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.57 | ||
| Q1 24 | — | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | $341.7M | $-18.2M |
| 总资产 | $461.5M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBRDI
| Q4 25 | $90.9M | $10.5M | ||
| Q3 25 | $93.3M | $8.1M | ||
| Q2 25 | $75.5M | $9.1M | ||
| Q1 25 | $95.3M | $5.9M | ||
| Q4 24 | $98.7M | $12.4M | ||
| Q3 24 | $162.3M | $10.1M | ||
| Q2 24 | $177.9M | $9.3M | ||
| Q1 24 | $168.8M | $7.5M |
总债务CTKBRDI
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CTKBRDI
| Q4 25 | $341.7M | $-18.2M | ||
| Q3 25 | $378.6M | $-12.1M | ||
| Q2 25 | $377.6M | $-7.7M | ||
| Q1 25 | $379.6M | $-8.1M | ||
| Q4 24 | $395.7M | $-4.4M | ||
| Q3 24 | $385.5M | $1.6M | ||
| Q2 24 | $389.1M | $6.5M | ||
| Q1 24 | $392.6M | $18.0M |
总资产CTKBRDI
| Q4 25 | $461.5M | $434.9M | ||
| Q3 25 | $494.9M | $435.2M | ||
| Q2 25 | $493.3M | $438.1M | ||
| Q1 25 | $482.6M | $441.0M | ||
| Q4 24 | $499.5M | $471.0M | ||
| Q3 24 | $491.2M | $495.7M | ||
| Q2 24 | $483.7M | $494.9M | ||
| Q1 24 | $492.1M | $494.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $4.1M |
| 自由现金流率自由现金流/营收 | -2.9% | 8.2% |
| 资本支出强度资本支出/营收 | 1.6% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $-2.9M |
8季度趋势，按日历期对齐
经营现金流CTKBRDI
| Q4 25 | $-771.0K | $4.3M | ||
| Q3 25 | $-3.9M | $295.0K | ||
| Q2 25 | $108.0K | $1.6M | ||
| Q1 25 | $-125.0K | $-7.7M | ||
| Q4 24 | $2.0M | $8.0M | ||
| Q3 24 | $13.2M | $1.3M | ||
| Q2 24 | $6.2M | $-10.4M | ||
| Q1 24 | $4.0M | $-2.8M |
自由现金流CTKBRDI
| Q4 25 | $-1.8M | $4.1M | ||
| Q3 25 | $-4.6M | $-246.0K | ||
| Q2 25 | $-1.5M | $1.2M | ||
| Q1 25 | $-974.0K | $-8.0M | ||
| Q4 24 | $1.1M | $7.0M | ||
| Q3 24 | $12.2M | $-1.1M | ||
| Q2 24 | $5.2M | $-10.6M | ||
| Q1 24 | $3.4M | $-4.7M |
自由现金流率CTKBRDI
| Q4 25 | -2.9% | 8.2% | ||
| Q3 25 | -8.7% | -0.5% | ||
| Q2 25 | -3.2% | 1.9% | ||
| Q1 25 | -2.3% | -19.8% | ||
| Q4 24 | 1.9% | 12.0% | ||
| Q3 24 | 23.7% | -1.8% | ||
| Q2 24 | 11.0% | -22.7% | ||
| Q1 24 | 7.6% | -10.4% |
资本支出强度CTKBRDI
| Q4 25 | 1.6% | 0.3% | ||
| Q3 25 | 1.3% | 1.0% | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 2.0% | 0.6% | ||
| Q4 24 | 1.6% | 1.7% | ||
| Q3 24 | 2.0% | 4.0% | ||
| Q2 24 | 2.3% | 0.5% | ||
| Q1 24 | 1.3% | 4.3% |
现金转化率CTKBRDI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
